• Welcome to Renmin Hospital of Wuhan University
  • 网站首页 中文版 English Francaise
    • 科室位置

    院内导航
    张振涛 神经病学
    教授，主任医师，博士生导师，神经内科主任，神经精神医院副院长
    A+ A-
    科室及职务

    诊疗专长

    姓名 张振涛
    出生年月 1981年
    单位 武汉大学人民医院神经内科
    所属学科 临床医学-神经病学
    职务、职称及头衔 教授，主任医师，博士生导师，神经内科主任，神经精神医院副院长
    E-mail zhentaozhang@whu.edu.cn
    联系方式 027-88041911转82221
    研究方向 1.帕金森病
    2.阿尔茨海默病
    个人简介
    一直致力于帕金森病和阿尔茨海默病的发病机制及诊疗策略研究，主持国家重点研发计划、国家优秀青年科学基金、国家自然科学基金、湖北省杰出青年科学基金等科研项目，代表性论著发表在Cell、Nature Medicine、Nature Communications、Nature Structural & Molecular Biology、Nature Aging、Science Advances等期刊。目前正在培养的博士生10名，硕士生7名。
    学术任职与荣誉
    1. “百千国家级人才才工程”国家级人选
    2. 获国家“有突出贡献中青年专家”称号
    3. 国务院政府特殊津贴专家
    4. 获国家“优秀青年科学基金”资助
    5. 获湖北省“杰出青年科学基金”资助
    6. 中华医学会神经病学分会帕金森病及运动障碍学组委员
    7. 中国医师协会神经内科医师分会帕金森病及运动障碍学组委员
    8. 中国睡眠研究会睡眠生理与药理专委会副主任委员
    教育履历
    2007年9月-2010年6月，华中科技大学同济医学院，博士研究生，神经病学；
    2004年9月-2007年6月，华中科技大学同济医学院，硕士研究生，神经病学；
    1999年9月-2004年6月，潍坊医学院医学系，本科，临床医学。
    工作履历
    2017年12月至今，武汉大学人民医院神经内科，教授，主任医师；
    2016年11月至2017年11月，武汉大学人民医院神经内科，教授，副主任医师；
    2015年2月至2016年10月，美国Emory大学，助理教授；
    2012年2月－2015年1月，美国Emory大学，博士后；
    2010年7月－2012年1月，武汉大学人民医院神经内科，主治医师。
    成果获奖
    获得中国医师协会“中国杰出神经内科医师”奖、湖北省科技进步奖一等奖（排名第二）
    代表性论著
    1. Pan L#, Li C#, Meng L, Zhang G, Zou L, Tian Y, Chen S, Sun Y, Su D, Zhang X, Xiong M, Xiao T, Xia D, Hong Z, Zhang Z*. GDF1 ameliorates cognitive impairment induced by hearing loss. Nature Aging, 2024, 4(4):568-583.
    2. Yang Y#, Chen S#, Zhang L#, Zhang G, Liu Y, Li Y, Zou L, Meng L, Tian Y, Dai L, Xiong M, Pan L, Xiong J, Chen L, Hou H, Yu Z, Zhang Z*. The PM20D1-NADA pathway protects against Parkinson's disease. Cell Death Differ, 2024. doi: 10.1038/s41418-024-01356-9.
    3. Wang J#, Dai L#, Chen S, Zhang Z, Fang X, Zhang Z*. Protein-protein interactions regulating α-synuclein pathology. Trends in Neurosciences, 2024, 47(3):209-226.
    4. Guo T#, Zhou L#, Xiong M, Xiong J, Huang J, Li Y, Zhang G, Chen G, Wang ZH, Xiao T, Hu D, Bao A, Zhang Z*. N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson's disease. Aging Cell, 2024:e14124.
    5. Zhu M#, Zhang G#, Meng L, Xiao T, Fang X*, Zhang Z*. Physiological and pathological functions of TMEM106B in neurodegenerative diseases. Cell Mol Life Sci, 2024, 81(1):209.
    6. Guo T#, Xiong J#, Feng H, Bu L, Xiao T, Zhou L, He J, Deng M, Liu Y*, Zhang Z*, Zhang Z*. L116 Deletion in CSPα Promotes α-Synuclein Aggregation and Neurodegeneration. Molecular Neurobiology, 2024, 61(1):15-27.
    7. Zhang X, Zou L, Tang L, Xiong M, Yan XX, Meng L, Chen G, Xiong J, Nie S, Zhang Z, Chen Q, Zhang Z*. Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice. PLoS Biol, 2024, 22(1):e3002470.
    8. Xiang J#, Tao Y#, Xia Y#, Luo S, Zhao Q, Li B, Zhang X, Sun Y, Xia W, Zhang M, Kang SS, Ahn EH, Liu X, Xie F, Guan Y, Yang JJ, Bu L, Wu S, Wang X, Cao X, Liu C, Zhang Z*, Li D*, Ye K*. Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies. Cell, 2023, 186(16):3350-3367.
    9. Meng L, Liu C, Li Y, Chen G, Xiong M, Yu T, Pan L, Zhang X, Zhou L, Guo T, Yuan X, Liu C, Zhang Z, Zhang Z*. The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson's disease. Sci Adv, 2023, 9(44):eadj1092.
    10. Zhang X#, Tang L#, Yang J, Meng L, Chen J, Zhou L, Wang J, Xiong M, Zhang Z*. Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer's disease. Nat Commun, 2023, 14(1):6670.
    11. Yu T#, Nie S#, Bu L, Liu M, He J, Niu X, Feng H, Guo J, Tang B, Zhang Z, Ye K, Jiang H, Chen L, Zhang Z*. Cholestanol accelerates α-synuclein aggregation and spreading by activating asparagine endopeptidase. JCI Insight, 2023, 8(21):e165841.
    12. Meng L#, Liu C#, Liu M, Chen J, Liu C, Zhang Z, Chen G, Zhang Z*. The yeast protein Ure2p triggers Tau pathology in a mouse model of tauopathy. Cell Rep, 2023, 42(11):113342.
    13. Yan M#, Tang L#, Dai L, Lei C, Xiong M, Zhang X, He M, Tian Y, Xiong J, Ke W, Zhang Z, Zhang C, Deng X, Zhang Z*. Cofilin promotes tau pathology in Alzheimer’s disease. Cell Reports, 2023, 42(2):112138.
    14. Zhou L#, Guo T#, Meng L, Zhang X, Tian Y, Dai L, Niu X, Li Y, Liu C, Chen G, Liu C, Ke W, Zhang Z, Bao A*, Zhang Z*. N-homocysteinylation of α-synuclein promotes its aggregation and neurotoxicity. Aging Cell, 2023: e13745.
    15. Liu C#*, Liu Z#, Fang Y, Liao Z, Zhang Z, Yuan X, Yu T, Yang Y, Xiong M, Zhang X, Zhang G, Meng L, Zhang Z*. Exposure to dithiocarbamate fungicide maneb in vitro and in vivo: Neuronal apoptosis and underlying mechanisms. Environment International, 2023, 171:107696.
    16. Pan L#, Li C#, Meng L, Tian Y, He M, Yuan X, Zhang G, Zhang Z, Xiong J, Chen G, Zhang Z*. Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease. Brain, 2022, 145(10):3454-3471.
    17. Zhang G#, Meng L#, Wang Z, Peng Q, Chen G, Xiong J, Zhang Z*. Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer's disease. Molecular Neurodegeneration, 2022, 17(1):12.
    18. Meng L#, Zou L, Xiong M, Chen J, Zhang X, Yu T, Li Y, Liu C, Chen G, Wang Z, Ye K, Zhang Z*. A synapsinⅠcleavage fragment contributes to synaptic dysfunction in Alzheimer's disease. Aging Cell, 2022, 21(5):e13619.
    19. Kang SS#, Meng L, Zhang X, Wu Z, Mancieri A, Xie B, Liu X, Weinshenker D, Peng J, Zhang Z*, Ye K*. Tau modification by the norepinephrine metabolite DOPEGAL stimulates its pathology and propagation. Nature Structural & Molecular Biology, 2022, 29(4):292-305.
    Name Zhentao Zhang
    Date of birth Oct. 1981
    Department Department of Neurology, Renmin Hospital of Wuhan University
    Title Professor, Chief physician. Director of the Department of Neurology
    Email zhentaozhang@whu.edu.cn
    TEL 027-88041911-82221
    Research Direction
    1. Parkinson's disease; 2. Alzheimer's disease
    Personal Profile
    Zhentao Zhang is a professor in the Department of Neurology, Renmin Hospital of Wuhan University. He majors in the clinical and basic research of neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. His group focusses on the molecular mechanisms of neuronal degeneration. He has published several papers on top journals such asCell,Nature Medicine, Nature Structural & Molecular Biology, Nature Communications, and Nature Aging.
    Selected Publications
    1. Pan L#, Li C#, Meng L, Zhang G, Zou L, Tian Y, Chen S, Sun Y, Su D, Zhang X, Xiong M, Xiao T, Xia D, Hong Z, Zhang Z*. GDF1 ameliorates cognitive impairment induced by hearing loss. Nature Aging, 2024, 4(4):568-583.
    2. Yang Y#, Chen S#, Zhang L#, Zhang G, Liu Y, Li Y, Zou L, Meng L, Tian Y, Dai L, Xiong M, Pan L, Xiong J, Chen L, Hou H, Yu Z, Zhang Z*. The PM20D1-NADA pathway protects against Parkinson's disease. Cell Death Differ, 2024. doi: 10.1038/s41418-024-01356-9.
    3. Wang J#, Dai L#, Chen S, Zhang Z, Fang X, Zhang Z*. Protein-protein interactions regulating α-synuclein pathology. Trends in Neurosciences, 2024, 47(3):209-226.
    4. Guo T#, Zhou L#, Xiong M, Xiong J, Huang J, Li Y, Zhang G, Chen G, Wang ZH, Xiao T, Hu D, Bao A, Zhang Z*. N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson's disease. Aging Cell, 2024:e14124.
    5. Zhu M#, Zhang G#, Meng L, Xiao T, Fang X*, Zhang Z*. Physiological and pathological functions of TMEM106B in neurodegenerative diseases. Cell Mol Life Sci, 2024, 81(1):209.
    6. Guo T#, Xiong J#, Feng H, Bu L, Xiao T, Zhou L, He J, Deng M, Liu Y*, Zhang Z*, Zhang Z*. L116 Deletion in CSPα Promotes α-Synuclein Aggregation and Neurodegeneration. Molecular Neurobiology, 2024, 61(1):15-27.
    7. Zhang X, Zou L, Tang L, Xiong M, Yan XX, Meng L, Chen G, Xiong J, Nie S, Zhang Z, Chen Q, Zhang Z*. Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice. PLoS Biol, 2024, 22(1):e3002470.
    8. Xiang J#, Tao Y#, Xia Y#, Luo S, Zhao Q, Li B, Zhang X, Sun Y, Xia W, Zhang M, Kang SS, Ahn EH, Liu X, Xie F, Guan Y, Yang JJ, Bu L, Wu S, Wang X, Cao X, Liu C, Zhang Z*, Li D*, Ye K*. Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies. Cell, 2023, 186(16):3350-3367.
    9. Meng L, Liu C, Li Y, Chen G, Xiong M, Yu T, Pan L, Zhang X, Zhou L, Guo T, Yuan X, Liu C, Zhang Z, Zhang Z*. The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson's disease. Sci Adv, 2023, 9(44):eadj1092.
    10. Zhang X#, Tang L#, Yang J, Meng L, Chen J, Zhou L, Wang J, Xiong M, Zhang Z*. Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer's disease. Nat Commun, 2023, 14(1):6670.
    11. Yu T#, Nie S#, Bu L, Liu M, He J, Niu X, Feng H, Guo J, Tang B, Zhang Z, Ye K, Jiang H, Chen L, Zhang Z*. Cholestanol accelerates α-synuclein aggregation and spreading by activating asparagine endopeptidase. JCI Insight, 2023, 8(21):e165841.
    12. Meng L#, Liu C#, Liu M, Chen J, Liu C, Zhang Z, Chen G, Zhang Z*. The yeast protein Ure2p triggers Tau pathology in a mouse model of tauopathy. Cell Rep, 2023, 42(11):113342.
    13. Yan M#, Tang L#, Dai L, Lei C, Xiong M, Zhang X, He M, Tian Y, Xiong J, Ke W, Zhang Z, Zhang C, Deng X, Zhang Z*. Cofilin promotes tau pathology in Alzheimer’s disease. Cell Reports, 2023, 42(2):112138.
    14. Zhou L#, Guo T#, Meng L, Zhang X, Tian Y, Dai L, Niu X, Li Y, Liu C, Chen G, Liu C, Ke W, Zhang Z, Bao A*, Zhang Z*. N-homocysteinylation of α-synuclein promotes its aggregation and neurotoxicity. Aging Cell, 2023: e13745.
    15. Liu C#*, Liu Z#, Fang Y, Liao Z, Zhang Z, Yuan X, Yu T, Yang Y, Xiong M, Zhang X, Zhang G, Meng L, Zhang Z*. Exposure to dithiocarbamate fungicide maneb in vitro and in vivo: Neuronal apoptosis and underlying mechanisms. Environment International, 2023, 171:107696.
    16. Pan L#, Li C#, Meng L, Tian Y, He M, Yuan X, Zhang G, Zhang Z, Xiong J, Chen G, Zhang Z*. Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease. Brain, 2022, 145(10):3454-3471.
    17. Zhang G#, Meng L#, Wang Z, Peng Q, Chen G, Xiong J, Zhang Z*. Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer's disease. Molecular Neurodegeneration, 2022, 17(1):12.
    18. Meng L#, Zou L, Xiong M, Chen J, Zhang X, Yu T, Li Y, Liu C, Chen G, Wang Z, Ye K, Zhang Z*. A synapsinⅠcleavage fragment contributes to synaptic dysfunction in Alzheimer's disease. Aging Cell, 2022, 21(5):e13619.
    19. Kang SS#, Meng L, Zhang X, Wu Z, Mancieri A, Xie B, Liu X, Weinshenker D, Peng J, Zhang Z*, Ye K*. Tau modification by the norepinephrine metabolite DOPEGAL stimulates its pathology and propagation. Nature Structural & Molecular Biology, 2022, 29(4):292-305.

    学术任职与荣誉

    科研成果

    出诊医生 星期一 星期二 星期三 星期四 星期五 星期六 星期日
    上午 下午 上午 下午 上午 下午 上午 下午 上午 下午 上午 下午 上午 下午
    张振涛
    预约方式

    张振涛

    神经病学

    教授，主任医师，博士生导师，神经内科主任，神经精神医院副院长

    诊疗专长：

    姓名 张振涛
    出生年月 1981年
    单位 武汉大学人民医院神经内科
    所属学科 临床医学-神经病学
    职务、职称及头衔 教授，主任医师，博士生导师，神经内科主任，神经精神医院副院长
    E-mail zhentaozhang@whu.edu.cn
    联系方式 027-88041911转82221
    研究方向 1.帕金森病
    2.阿尔茨海默病
    个人简介
    一直致力于帕金森病和阿尔茨海默病的发病机制及诊疗策略研究，主持国家重点研发计划、国家优秀青年科学基金、国家自然科学基金、湖北省杰出青年科学基金等科研项目，代表性论著发表在Cell、Nature Medicine、Nature Communications、Nature Structural & Molecular Biology、Nature Aging、Science Advances等期刊。目前正在培养的博士生10名，硕士生7名。
    学术任职与荣誉
    1. “百千国家级人才才工程”国家级人选
    2. 获国家“有突出贡献中青年专家”称号
    3. 国务院政府特殊津贴专家
    4. 获国家“优秀青年科学基金”资助
    5. 获湖北省“杰出青年科学基金”资助
    6. 中华医学会神经病学分会帕金森病及运动障碍学组委员
    7. 中国医师协会神经内科医师分会帕金森病及运动障碍学组委员
    8. 中国睡眠研究会睡眠生理与药理专委会副主任委员
    教育履历
    2007年9月-2010年6月，华中科技大学同济医学院，博士研究生，神经病学；
    2004年9月-2007年6月，华中科技大学同济医学院，硕士研究生，神经病学；
    1999年9月-2004年6月，潍坊医学院医学系，本科，临床医学。
    工作履历
    2017年12月至今，武汉大学人民医院神经内科，教授，主任医师；
    2016年11月至2017年11月，武汉大学人民医院神经内科，教授，副主任医师；
    2015年2月至2016年10月，美国Emory大学，助理教授；
    2012年2月－2015年1月，美国Emory大学，博士后；
    2010年7月－2012年1月，武汉大学人民医院神经内科，主治医师。
    成果获奖
    获得中国医师协会“中国杰出神经内科医师”奖、湖北省科技进步奖一等奖（排名第二）
    代表性论著
    1. Pan L#, Li C#, Meng L, Zhang G, Zou L, Tian Y, Chen S, Sun Y, Su D, Zhang X, Xiong M, Xiao T, Xia D, Hong Z, Zhang Z*. GDF1 ameliorates cognitive impairment induced by hearing loss. Nature Aging, 2024, 4(4):568-583.
    2. Yang Y#, Chen S#, Zhang L#, Zhang G, Liu Y, Li Y, Zou L, Meng L, Tian Y, Dai L, Xiong M, Pan L, Xiong J, Chen L, Hou H, Yu Z, Zhang Z*. The PM20D1-NADA pathway protects against Parkinson's disease. Cell Death Differ, 2024. doi: 10.1038/s41418-024-01356-9.
    3. Wang J#, Dai L#, Chen S, Zhang Z, Fang X, Zhang Z*. Protein-protein interactions regulating α-synuclein pathology. Trends in Neurosciences, 2024, 47(3):209-226.
    4. Guo T#, Zhou L#, Xiong M, Xiong J, Huang J, Li Y, Zhang G, Chen G, Wang ZH, Xiao T, Hu D, Bao A, Zhang Z*. N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson's disease. Aging Cell, 2024:e14124.
    5. Zhu M#, Zhang G#, Meng L, Xiao T, Fang X*, Zhang Z*. Physiological and pathological functions of TMEM106B in neurodegenerative diseases. Cell Mol Life Sci, 2024, 81(1):209.
    6. Guo T#, Xiong J#, Feng H, Bu L, Xiao T, Zhou L, He J, Deng M, Liu Y*, Zhang Z*, Zhang Z*. L116 Deletion in CSPα Promotes α-Synuclein Aggregation and Neurodegeneration. Molecular Neurobiology, 2024, 61(1):15-27.
    7. Zhang X, Zou L, Tang L, Xiong M, Yan XX, Meng L, Chen G, Xiong J, Nie S, Zhang Z, Chen Q, Zhang Z*. Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice. PLoS Biol, 2024, 22(1):e3002470.
    8. Xiang J#, Tao Y#, Xia Y#, Luo S, Zhao Q, Li B, Zhang X, Sun Y, Xia W, Zhang M, Kang SS, Ahn EH, Liu X, Xie F, Guan Y, Yang JJ, Bu L, Wu S, Wang X, Cao X, Liu C, Zhang Z*, Li D*, Ye K*. Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies. Cell, 2023, 186(16):3350-3367.
    9. Meng L, Liu C, Li Y, Chen G, Xiong M, Yu T, Pan L, Zhang X, Zhou L, Guo T, Yuan X, Liu C, Zhang Z, Zhang Z*. The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson's disease. Sci Adv, 2023, 9(44):eadj1092.
    10. Zhang X#, Tang L#, Yang J, Meng L, Chen J, Zhou L, Wang J, Xiong M, Zhang Z*. Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer's disease. Nat Commun, 2023, 14(1):6670.
    11. Yu T#, Nie S#, Bu L, Liu M, He J, Niu X, Feng H, Guo J, Tang B, Zhang Z, Ye K, Jiang H, Chen L, Zhang Z*. Cholestanol accelerates α-synuclein aggregation and spreading by activating asparagine endopeptidase. JCI Insight, 2023, 8(21):e165841.
    12. Meng L#, Liu C#, Liu M, Chen J, Liu C, Zhang Z, Chen G, Zhang Z*. The yeast protein Ure2p triggers Tau pathology in a mouse model of tauopathy. Cell Rep, 2023, 42(11):113342.
    13. Yan M#, Tang L#, Dai L, Lei C, Xiong M, Zhang X, He M, Tian Y, Xiong J, Ke W, Zhang Z, Zhang C, Deng X, Zhang Z*. Cofilin promotes tau pathology in Alzheimer’s disease. Cell Reports, 2023, 42(2):112138.
    14. Zhou L#, Guo T#, Meng L, Zhang X, Tian Y, Dai L, Niu X, Li Y, Liu C, Chen G, Liu C, Ke W, Zhang Z, Bao A*, Zhang Z*. N-homocysteinylation of α-synuclein promotes its aggregation and neurotoxicity. Aging Cell, 2023: e13745.
    15. Liu C#*, Liu Z#, Fang Y, Liao Z, Zhang Z, Yuan X, Yu T, Yang Y, Xiong M, Zhang X, Zhang G, Meng L, Zhang Z*. Exposure to dithiocarbamate fungicide maneb in vitro and in vivo: Neuronal apoptosis and underlying mechanisms. Environment International, 2023, 171:107696.
    16. Pan L#, Li C#, Meng L, Tian Y, He M, Yuan X, Zhang G, Zhang Z, Xiong J, Chen G, Zhang Z*. Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease. Brain, 2022, 145(10):3454-3471.
    17. Zhang G#, Meng L#, Wang Z, Peng Q, Chen G, Xiong J, Zhang Z*. Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer's disease. Molecular Neurodegeneration, 2022, 17(1):12.
    18. Meng L#, Zou L, Xiong M, Chen J, Zhang X, Yu T, Li Y, Liu C, Chen G, Wang Z, Ye K, Zhang Z*. A synapsinⅠcleavage fragment contributes to synaptic dysfunction in Alzheimer's disease. Aging Cell, 2022, 21(5):e13619.
    19. Kang SS#, Meng L, Zhang X, Wu Z, Mancieri A, Xie B, Liu X, Weinshenker D, Peng J, Zhang Z*, Ye K*. Tau modification by the norepinephrine metabolite DOPEGAL stimulates its pathology and propagation. Nature Structural & Molecular Biology, 2022, 29(4):292-305.
    Name Zhentao Zhang
    Date of birth Oct. 1981
    Department Department of Neurology, Renmin Hospital of Wuhan University
    Title Professor, Chief physician. Director of the Department of Neurology
    Email zhentaozhang@whu.edu.cn
    TEL 027-88041911-82221
    Research Direction
    1. Parkinson's disease; 2. Alzheimer's disease
    Personal Profile
    Zhentao Zhang is a professor in the Department of Neurology, Renmin Hospital of Wuhan University. He majors in the clinical and basic research of neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. His group focusses on the molecular mechanisms of neuronal degeneration. He has published several papers on top journals such asCell,Nature Medicine, Nature Structural & Molecular Biology, Nature Communications, and Nature Aging.
    Selected Publications
    1. Pan L#, Li C#, Meng L, Zhang G, Zou L, Tian Y, Chen S, Sun Y, Su D, Zhang X, Xiong M, Xiao T, Xia D, Hong Z, Zhang Z*. GDF1 ameliorates cognitive impairment induced by hearing loss. Nature Aging, 2024, 4(4):568-583.
    2. Yang Y#, Chen S#, Zhang L#, Zhang G, Liu Y, Li Y, Zou L, Meng L, Tian Y, Dai L, Xiong M, Pan L, Xiong J, Chen L, Hou H, Yu Z, Zhang Z*. The PM20D1-NADA pathway protects against Parkinson's disease. Cell Death Differ, 2024. doi: 10.1038/s41418-024-01356-9.
    3. Wang J#, Dai L#, Chen S, Zhang Z, Fang X, Zhang Z*. Protein-protein interactions regulating α-synuclein pathology. Trends in Neurosciences, 2024, 47(3):209-226.
    4. Guo T#, Zhou L#, Xiong M, Xiong J, Huang J, Li Y, Zhang G, Chen G, Wang ZH, Xiao T, Hu D, Bao A, Zhang Z*. N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson's disease. Aging Cell, 2024:e14124.
    5. Zhu M#, Zhang G#, Meng L, Xiao T, Fang X*, Zhang Z*. Physiological and pathological functions of TMEM106B in neurodegenerative diseases. Cell Mol Life Sci, 2024, 81(1):209.
    6. Guo T#, Xiong J#, Feng H, Bu L, Xiao T, Zhou L, He J, Deng M, Liu Y*, Zhang Z*, Zhang Z*. L116 Deletion in CSPα Promotes α-Synuclein Aggregation and Neurodegeneration. Molecular Neurobiology, 2024, 61(1):15-27.
    7. Zhang X, Zou L, Tang L, Xiong M, Yan XX, Meng L, Chen G, Xiong J, Nie S, Zhang Z, Chen Q, Zhang Z*. Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice. PLoS Biol, 2024, 22(1):e3002470.
    8. Xiang J#, Tao Y#, Xia Y#, Luo S, Zhao Q, Li B, Zhang X, Sun Y, Xia W, Zhang M, Kang SS, Ahn EH, Liu X, Xie F, Guan Y, Yang JJ, Bu L, Wu S, Wang X, Cao X, Liu C, Zhang Z*, Li D*, Ye K*. Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies. Cell, 2023, 186(16):3350-3367.
    9. Meng L, Liu C, Li Y, Chen G, Xiong M, Yu T, Pan L, Zhang X, Zhou L, Guo T, Yuan X, Liu C, Zhang Z, Zhang Z*. The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson's disease. Sci Adv, 2023, 9(44):eadj1092.
    10. Zhang X#, Tang L#, Yang J, Meng L, Chen J, Zhou L, Wang J, Xiong M, Zhang Z*. Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer's disease. Nat Commun, 2023, 14(1):6670.
    11. Yu T#, Nie S#, Bu L, Liu M, He J, Niu X, Feng H, Guo J, Tang B, Zhang Z, Ye K, Jiang H, Chen L, Zhang Z*. Cholestanol accelerates α-synuclein aggregation and spreading by activating asparagine endopeptidase. JCI Insight, 2023, 8(21):e165841.
    12. Meng L#, Liu C#, Liu M, Chen J, Liu C, Zhang Z, Chen G, Zhang Z*. The yeast protein Ure2p triggers Tau pathology in a mouse model of tauopathy. Cell Rep, 2023, 42(11):113342.
    13. Yan M#, Tang L#, Dai L, Lei C, Xiong M, Zhang X, He M, Tian Y, Xiong J, Ke W, Zhang Z, Zhang C, Deng X, Zhang Z*. Cofilin promotes tau pathology in Alzheimer’s disease. Cell Reports, 2023, 42(2):112138.
    14. Zhou L#, Guo T#, Meng L, Zhang X, Tian Y, Dai L, Niu X, Li Y, Liu C, Chen G, Liu C, Ke W, Zhang Z, Bao A*, Zhang Z*. N-homocysteinylation of α-synuclein promotes its aggregation and neurotoxicity. Aging Cell, 2023: e13745.
    15. Liu C#*, Liu Z#, Fang Y, Liao Z, Zhang Z, Yuan X, Yu T, Yang Y, Xiong M, Zhang X, Zhang G, Meng L, Zhang Z*. Exposure to dithiocarbamate fungicide maneb in vitro and in vivo: Neuronal apoptosis and underlying mechanisms. Environment International, 2023, 171:107696.
    16. Pan L#, Li C#, Meng L, Tian Y, He M, Yuan X, Zhang G, Zhang Z, Xiong J, Chen G, Zhang Z*. Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease. Brain, 2022, 145(10):3454-3471.
    17. Zhang G#, Meng L#, Wang Z, Peng Q, Chen G, Xiong J, Zhang Z*. Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer's disease. Molecular Neurodegeneration, 2022, 17(1):12.
    18. Meng L#, Zou L, Xiong M, Chen J, Zhang X, Yu T, Li Y, Liu C, Chen G, Wang Z, Ye K, Zhang Z*. A synapsinⅠcleavage fragment contributes to synaptic dysfunction in Alzheimer's disease. Aging Cell, 2022, 21(5):e13619.
    19. Kang SS#, Meng L, Zhang X, Wu Z, Mancieri A, Xie B, Liu X, Weinshenker D, Peng J, Zhang Z*, Ye K*. Tau modification by the norepinephrine metabolite DOPEGAL stimulates its pathology and propagation. Nature Structural & Molecular Biology, 2022, 29(4):292-305.



    友情链接：湖北省人民政府武汉大学国家卫生健康委员会湖北省卫生健康委员会中华人民共和国教育部中华人民共和国科技部武汉市卫生健康委员会
    武汉大学人民医院 湖北省人民医院
    湖北省人民医院 武汉大学人民医院

    医院概况 | English | Francaise | 站点地图

    医院地址：湖北省武汉市武昌区张之洞路99号解放路238号 邮编：430060 邮箱：whdxrmyy&126.com

    Copyrights©2002-2024 All Rights Reserved. 武汉大学人民医院 湖北省人民医院 版权所有

    鄂ICP备：19028677号 鄂公网安备：42010602002990号 如有转载或引用本站文章涉及版权问题，请与我们联系